NEXUS AG: Continued Sales and Operating Result Increase in the first Quarter 2017

Donaueschingen, 9 May 2017: NEXUS AG, specialized in hospital software, was able to increase sales by approx. 11 % and its Group result for earnings before interest and taxes by approx. 13 % in the first quarter 2017. As a result, the long-term growth course of the NEXUS Group could be continued.

Sales increased by approx. 10.8 % from KEUR 26,113 (3M-2016) to KEUR 28,940 in the first quarter 2017. In the Healthcare Software Division, sales increased by 6.6 % (3M-2017: KEUR 25,932; 3M-2016: KEUR 24,335). The Healthcare Service Division recorded sales of KEUR 3,008 in the first quarter 2017 after KEUR 1,778 (3M-2016) and consequently 69.2 % more than in the previous year. The international share of total business volume was 50.7 % (previous year: 51.2 %) and increased to KEUR 14,664 after KEUR 13,358 of the previous year.

The Group result for earnings before interest and taxes (EBIT) improved from KEUR 2,590 (3M-2016) to KEUR 2,926. A value of KEUR 3,520 was achieved in EBITA and consequently was 11.5 % above the value of previous year (3M-2016 adjusted KEUR 3,157). EBITDA was KEUR 5,411 in the first quarter of 2017 (3M-2016: KEUR 4,839) and consequently was 11.8 % higher than the previous year. The consolidated surplus amounted to KEUR 2,503 for the first quarter 2017 following KEUR 2,353 (3M-2016) and consequently increased by 6.4 %.

The cash flow in the first quarter developed especially strongly. The cash flow from current business transactions reached KEUR 18,153 and consequently considerably surpassed the high value of the previous year of KEUR 13,977 (+29.9 %). NEXUS AG had cash funds incl. short-term financial assets amounting to KEUR 34,111 as of 31 March 2017 (31 March 2016: KEUR 32,902).

The undiluted earnings per share amounted to 15 cents (previous year: 14 cents) (diluted: 15 cents; previous year: 14 cents).

NEXUS AG has equity capital amounting to KEUR 98,344 (31 Dec. 2016: KEUR 95,802). This demonstrates that NEXUS AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.